VERIFIEDMint Markets·7 Oct 2026neutral

Sun Pharma to consider ₹15,000 crore NCD issue; board meeting on 12 October

AI Summary

·Sun Pharmaceutical Industries will hold a board meeting on October 12, 2026.
·The meeting will consider approving the issuance of non-convertible debentures.
·The proposed NCD issue is valued at up to ₹15,000 crore.